Results

• All
• Video
• Audio
• Images

• Most recent
• Filter by category

1–2 of 2 results for neuroprotection

• 

  ARCHER II, a Phase 3 Randomized Clinical Trial of ANX007 in Patients With Dry AMD and GA: Study Design andRationale Informed by Outcomes From ARCHER

  David A. Eichenbaum, MD, FASRS

  Annual Meeting Talks

  2025

• 

  Beyond Complement: A Novel FAS Inhibition Approach for Neuroprotection in GA

  Vaidehi S. Dedania, MD

  Updates from the Field

  2024